Labeler
Amneal Pharmaceuticals NY LLC NDC Codes
Amneal Pharmaceuticals NY LLC lists 331 finished drug products in the FDA NDC Directory under NDC labeler codes 60219, 69238.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Eltrombopag Olamine, Isotretinoin, Lenalidomide, Estradiol, Amlodipine Besylate and Benazepril Hydrochloride, Deflazacort, Carvedilol Phosphate, Tacrolimus, prednisolone acetate, Sacubitril and Valsartan, Loteprednol Etabonate, Everolimus, Ciprofloxacin, Mirabegron, Sertraline HCl
- Active ingredients
- Eltrombopag olamine, Isotretinoin, Lenalidomide, Estradiol, Amlodipine besylate, Benazepril hydrochloride, Deflazacort, Carvedilol phosphate, Tacrolimus, Prednisolone acetate, Sacubitril, Valsartan
- NDC labeler codes
- 60219, 69238
- Strengths (from the 100 most recently listed products)
- Prednisolone acetate 10 mg/mL; Benazepril hydrochloride 10 mg/1; Amlodipine besylate 5 mg/1; Benazepril hydrochloride 20 mg/1; Eltrombopag olamine 75 mg/1; Eltrombopag olamine 50 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 12.5 mg/1; Neomycin sulfate 3.5 mg/mL; Polymyxin b sulfate 10000 [USP'U]/mL; Hydrocortisone 10 mg/mL; Pilocarpine hydrochloride 12.5 mg/mL; Loteprednol etabonate 2 mg/mL; Macitentan 10 mg/1; Tretinoin .8 mg/g; Etoposide 50 mg/1; Mirabegron 25 mg/1; Mirabegron 50 mg/1; Amlodipine besylate 2.5 mg/1; Amlodipine besylate 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Gel, Capsule, Extended release, Suspension/ drops, Tablet, Solution/ drops, Tablet, For suspension, Spray, Metered, Powder, For suspension, Suspension, Tablet, Film coated, Extended release, Aerosol, Metered, Cream, Kit, Inhalant, Patch, Extended release, Injection, Suspension, Suppository, Tablet, Delayed release, Spray, Granule, For solution, For solution, Solution
- Routes
- Oral, Ophthalmic, Topical, Nasal, Respiratory (Inhalation), Auricular (Otic), Transdermal, Intramuscular, Rectal
- Drug classes (FDA established)
- Corticosteroid, Thrombopoietin Receptor Agonist, Retinoid, Dihydropyridine Calcium Channel Blocker, Thalidomide Analog, Estrogen, Angiotensin Converting Enzyme Inhibitor, Calcium Channel Blocker, alpha-Adrenergic Blocker, beta-Adrenergic Blocker, Calcineurin Inhibitor Immunosuppressant, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Fluoroquinolone Antibacterial, beta3-Adrenergic Agonist, Serotonin Reuptake Inhibitor, Aminoglycoside Antibacterial, Polymyxin-class Antibacterial, Cholinergic Receptor Agonist, Serotonin-4 Receptor Agonist, Nonsteroidal Anti-inflammatory Drug, Serotonin-1b and Serotonin-1d Receptor Agonist, Protease Inhibitor, Macrolide Antimicrobial, Macrolide, Endothelin Receptor Antagonist, Topoisomerase Inhibitor, beta2-Adrenergic Agonist, Prostaglandin Analog, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Anticholinergic, Progestin, Reducing and Complexing Thiol, Ergot Derivative, Histamine-1 Receptor Antagonist, Histamine-2 Receptor Antagonist, Opioid Antagonist, Antimetabolite Immunosuppressant, Aluminum Complex, Phosphodiesterase 5 Inhibitor, Anti-epileptic Agent, Aldosterone Antagonist, Tricyclic Antidepressant, Glycopeptide Antibacterial, Sulfone
- HCPCS / J-code
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Clobetasol Propionate | Clobetasol propionate .05 g/100mL | ShampooTopical | 69238-1732 | 69238-1732-08 | — |
| etravirine | Etravirine 25 mg/1 | TabletOral | 60219-1720 | 60219-1720-07 | — |
| etravirine | Etravirine 100 mg/1 | TabletOral | 60219-1721 | 60219-1721-07 | — |
| etravirine | Etravirine 200 mg/1 | TabletOral | 60219-1722 | 60219-1722-06 | — |
| Propranolol Hydrochloride | Propranolol hydrochloride 10 mg/1 | TabletOral | 69238-2077 | 69238-2077-0169238-2077-07 | — |
| Propranolol Hydrochloride | Propranolol hydrochloride 20 mg/1 | TabletOral | 69238-2078 | 69238-2078-0169238-2078-07 | — |
| Propranolol Hydrochloride | Propranolol hydrochloride 40 mg/1 | TabletOral | 69238-2079 | 69238-2079-0169238-2079-07 | — |
| Propranolol Hydrochloride | Propranolol hydrochloride 60 mg/1 | TabletOral | 69238-2080 | 69238-2080-01 | — |
| Propranolol Hydrochloride | Propranolol hydrochloride 80 mg/1 | TabletOral | 69238-2081 | 69238-2081-0169238-2081-05 | — |
| Nitrofurantoin | Nitrofurantoin 25 mg/5mL | SuspensionOral | 69238-2512 | 69238-2512-09 | — |
| Norelgestromin and Ethinly Estradiol | Norelgestromin 150 ug/d; Ethinyl estradiol 35 ug/d | PatchTransdermal | 69238-1521 | 69238-1521-03 | — |
| Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride 10 mg/1 | CapsuleOral | 60219-1502 | 60219-1502-01 | — |
| Estradiol | Estradiol .0375 mg/d | Patch, Extended releaseTransdermal | 69238-1293 | 69238-1293-07 | — |
| Estradiol | Estradiol .075 mg/d | Patch, Extended releaseTransdermal | 69238-1294 | 69238-1294-07 | — |
| Estradiol | Estradiol .05 mg/d | Patch, Extended releaseTransdermal | 69238-1295 | 69238-1295-07 | — |
| Estradiol | Estradiol .1 mg/d | Patch, Extended releaseTransdermal | 69238-1296 | 69238-1296-07 | — |
| Estradiol | Estradiol .025 mg/d | Patch, Extended releaseTransdermal | 69238-1447 | 69238-1447-07 | — |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | 69238-1318 | 69238-1318-04 | — |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | 69238-1319 | 69238-1319-06 | — |
| Dimethyl Fumarate | — | Kit | 69238-1626 | 69238-1626-03 | — |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 10 mg/mL | Solution/ dropsOphthalmic | 69238-1745 | 69238-1745-08 | — |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 20 mg/mL | Solution/ dropsOphthalmic | 69238-1746 | 69238-1746-08 | — |
| Pilocarpine Hydrochloride | Pilocarpine hydrochloride 40 mg/mL | Solution/ dropsOphthalmic | 69238-1747 | 69238-1747-08 | — |
| Naproxen | Naproxen 25 mg/mL | SuspensionOral | 69238-1730 | 69238-1730-02 | — |
| fluphenazine hydrochloride | Fluphenazine hydrochloride 1 mg/1 | Tablet, Film coatedOral | 69238-1678 | 69238-1678-01 | — |
| fluphenazine hydrochloride | Fluphenazine hydrochloride 2.5 mg/1 | Tablet, Film coatedOral | 69238-1679 | 69238-1679-01 | — |
| fluphenazine hydrochloride | Fluphenazine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 69238-1680 | 69238-1680-01 | — |
| fluphenazine hydrochloride | Fluphenazine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 69238-1681 | 69238-1681-01 | — |
| prednisone | Prednisone 10 mg/1 | TabletOral | 60219-1707 | 60219-1707-0160219-1707-0360219-1707-05 | — |
| prednisone | Prednisone 20 mg/1 | TabletOral | 60219-1708 | 60219-1708-0160219-1708-05 | — |
| Deferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | 69238-1487 | 69238-1487-03 | — |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | 69238-1202 | 69238-1202-02 | — |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | 69238-1203 | 69238-1203-02 | — |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | 69238-1204 | 69238-1204-02 | — |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | 69238-1205 | 69238-1205-02 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | 69238-1505 | 69238-1505-02 | — |
| Ofloxacinofloxacin otic | Ofloxacin 3 mg/mL | SolutionAuricular (Otic) | 69238-1615 | 69238-1615-03 | — |
| Pyridostigmine Bromide | Pyridostigmine bromide 60 mg/5mL | SolutionOral | 69238-1731 | 69238-1731-02 | — |
| Deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | 69238-1486 | 69238-1486-03 | — |
| Deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | 69238-1488 | 69238-1488-03 | — |
| Sildenafil | Sildenafil 10 mg/mL | Powder, For suspensionOral | 69238-1574 | 69238-1574-01 | — |
| Enalapril Maleateenalapril | Enalapril maleate 1 mg/mL | SolutionOral | 69238-1729 | 69238-1729-07 | — |
| Erythromycin Ethylsuccinateerythromycin | Erythromycin ethylsuccinate 200 mg/5mL | SuspensionOral | 69238-1503 | 69238-1503-01 | — |
| Erythromycin Ethylsuccinateerythromycin | Erythromycin ethylsuccinate 400 mg/5mL | SuspensionOral | 69238-1504 | 69238-1504-02 | — |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | 69238-1594 | 69238-1594-03 | — |
| Ofloxacinofloxacin otic | Ofloxacin 3 mg/mL | SolutionAuricular (Otic) | 69238-1616 | 69238-1616-06 | — |
| Aminocaproic acid | Aminocaproic acid .25 g/mL | SolutionOral | 69238-1596 | 69238-1596-0469238-1596-08 | — |
| Pregabalin | Pregabalin 25 mg/1 | CapsuleOral | 69238-1310 | 69238-1310-0569238-1310-09 | — |
| Pregabalin | Pregabalin 50 mg/1 | CapsuleOral | 69238-1311 | 69238-1311-0569238-1311-09 | — |
| Pregabalin | Pregabalin 75 mg/1 | CapsuleOral | 69238-1312 | 69238-1312-0569238-1312-09 | — |
Amneal Pharmaceuticals NY LLC: common questions
- What is Amneal Pharmaceuticals NY LLC's NDC labeler code?
- 60219, 69238. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Amneal Pharmaceuticals NY LLC?
- Med-Code's HCPCS directory matches J1050 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.